Developing an Opioid Taper Intervention Before Total Joint Arthroplasty
Start Date
1/10/2024
Completion Date
7/1/2027
Summary
The goal of this clinical trial is to develop an pharmacist-led preoperative opioid taper intervention for patients undergoing total knee or hip replacement who are on chronic opioids before their surgery. The main questions it aims to answer are: * Is the intervention feasible and acceptable to patients? * Does the intervention result in a decrease in opioid dose during the preoperative period? Participants will meet with a clinical pharmacist, who will provide some basic education on pain and opioids, and will propose an opioid taper schedule. The pharmacist will then follow-up with the participant by phone each week until surgery to assess progress and adjust the taper as necessary.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
opioid taper
Conditions
Locations
UAB Hospital-Highlands
Birmingham, Alabama 35205
United States